DELRAY BEACH, Fla., March 14, 2017, PSID, (GLOBE NEWSWIRE) — PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today that its E-N-G Mobile Systems subsidiary (“ENG”) year-to-date bookings through February 28, 2017, total $1.7 million, which is an increase of more than 200 percent over total bookings in the prior sequential quarter.
Bookings represent signed purchase orders or contracts received from customers. The majority of the bookings are for ENG’s customized mobile lab vehicles. ENG’s MobiLab line is field-proven and available in a wide range of platforms including vans, truck-based systems and trailers up to 53 feet. Applications range from general purpose and chemistry labs to BSL3-ready and full CBRNE (chemical, biological, radiological, nuclear and explosives) threat detection and analysis.
“ENG’s pipeline is strong and we believe sets us up for another successful year,” stated Lyle L. Probst, President of PositiveID. “We have worked diligently to establish our mobile labs business amongst the best in the industry both domestically and internationally, and we believe the current pipeline for ENG’s mobile labs is evidence that hard work is paying off.”
ENG designs and builds mobile laboratories, wireless support vehicles (cell-on-wheels and cell-on-light-trucks), radio frequency (“RF”) test platforms, broadcast news vehicles, and other technical vehicles. ENG has delivered more than 1,400 specialty vehicles to customers around the globe, including more than 400 mobile laboratories, 600 broadcast news vehicles, and more than 400 vehicles for cellular, RF, infrared, and other applications.
About PositiveID Corporation
PositiveID Corporation is a life sciences tools and diagnostics company with an extensive patent portfolio. PositiveID develops biological detection and diagnostics systems, specializing in the development of microfluidic systems for the automated preparation of and performance of biological assays. PositiveID is also a leader in the mobile technology vehicle market, with a focus on the laboratory market and homeland security. For more information on PositiveID, please visit http://www.psidcorp.com, or connect with PositiveID on Twitter, Facebook or LinkedIn.
Statements about PositiveID’s future expectations, including the likelihood that ENG’s pipeline is strong and it sets up the company for another successful year; the likelihood that the current pipeline for ENG’s mobile labs is evidence that ENG’s mobile labs business amongst the best in the industry both domestically and internationally; constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. These risks and uncertainties include, without limitation, the Company’s ability to target the specialty vehicle market; the Company’s ability to attract new customers and retain existing customers; as well as other risks. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s various filings with the Securities and Exchange Commission, including those set forth in the Company’s 10-K filed on April 12, 2016, and 10-Qs filed on November 18, 2016, August 12, 2016, and May 16, 2016, under the caption “Risk Factors.” The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.